Summit Therapeutics plc Aktie
-
Deine Einschätzung
Was spricht für und gegen Summit Therapeutics plc in den nächsten Jahren?
Pro
Kontra
Rendite von Summit Therapeutics plc im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics plc | - | - | - | - | - | - | - |
| Proteome Sciences | 100,00 % | -58,06 % | -58,06 % | -79,03 % | -77,59 % | -81,69 % | -77,59 % |
| Oxford BioMedica PLC | -1,44 % | -5,44 % | -4,14 % | 43,60 % | 36,27 % | 103,22 % | -24,31 % |
| Sareum Holdings plc | - | 6,25 % | -7,83 % | -41,15 % | -49,34 % | -89,87 % | - |
Kommentare
News
What Did Goldman Sachs and Morgan Stanley CEOs Say to Spook the Market?
The U.S. stock market turned sharply lower Tuesday morning in reaction to seemingly negative comments by the CEOs of Morgan Stanley (NYSE: MS) and Goldman Sachs (NYSE: GS). At the Global Financial
Why Wall Street Is Backing These 3 Comeback Stocks
A company's comeback story can mean a significant opportunity for investors to win returns in the financial world. Of course, when a stock has shed a sizable portion of its value in recent memory
1 Monster Stock in the Making to Buy and Hold
What if you had invested in any of the current leaders in the biotech industry before they established themselves as such? You'd have earned terrific returns. While we can't go back in time to do



